MyAverix Finance
ST · Healthcare
Cereno Scientific AB Series B (CRNO-B)
Drug Manufacturers - Specialty & Generic
Cereno Scientific AB Series B (CRNO-B) is listed on ST in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CRNO-B
Cereno Scientific AB Series B (CRNO-B) — FAQ
What is CRNO-B's P/E ratio?
The price-to-earnings (P/E) ratio for Cereno Scientific AB Series B (CRNO-B) is 18.00 (data as of 2026-05-24).
Does Cereno Scientific AB Series B pay a dividend?
Dividend yield is not available in the current snapshot for Cereno Scientific AB Series B (CRNO-B). Check the MyAverix Finance app for the latest dividend data.
What sector is Cereno Scientific AB Series B in?
Cereno Scientific AB Series B (CRNO-B) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is CRNO-B listed on?
CRNO-B is listed on ST.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.